cover
Article Per Year (5 Year)
All
Home Page
OAI Link
Editorial Team
Contact
Reviewer
Google Scholar
Contact Name
Nurbeti Sinulingga
Contact Email
nurbetisinulingga14@gmail.com
Phone
+6285261645510
Journal Mail Official
nurbetisinulingga14@gmail.com
Editorial Address
Jl.Bilal No.52 Kel. Pulo Brayan Darat I Kec. Medan Timur
Location
Kota medan,
Sumatera utara
INDONESIA
JIFI (Jurnal Ilmiah Farmasi Imelda)
Published by Universitas Imelda Medan
ISSN : 26553147     EISSN : 25977164     DOI : https://doi.org/10.52943/jifarmasi.v5i1.623
Core Subject : Health, Science,
Biochemistry, Genetics & Molecular Biology Medicine & Pharmacology
JIFI (Imelda Pharmacy Scientific Journal) Imelda Imelda College of Health Sciences (STIKes) which is now Imelda University Medan received related articles: 1. Clinical Community Of Pharmacy 2. Pharmaceutical Technology 3. Pharmacy Management 4. Herbal medicines and Chemistry 5. Biology & Pharmacology JIFI (Jurnal Scientific Pharmacy Imelda) also accepts all writings with various disciplines on the condition that the core points remain in the path and scope of pharmaceutical science.
Arjuna Subject : Pharmacology, Toxicology and Pharmaceutics - Pharmacology, Toxicology and Pharmaceutics (Lain-Lain)
Articles 125 Documents
 9   10   11   12   13 
FORMULASI DAN UJI ANTIOKSIDAN SEDIAAN BODY SCRUB DARI EKSTRAK DAUN SRIKAYA (Annona squamosa L.) DENGAN METODE ABTS Susilowati, Ucik; Listyani, Tiara Ajeng; Raharjo, Danang
JIFI (Jurnal Ilmiah Farmasi Imelda) Vol. 9 No. 2 (2026): JIFI (Jurnal Ilmiah Farmasi Imelda)
Publisher : Universitas Imelda Medan

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.52943/jifarmasi.v9i2.2038

Abstract

IDENTIFIKASI ADVERSE DRUG REACTION (ADR) OBAT ANTI TUBERKULOSIS PADA PASIEN TB DI RSUD PASAR REBO JAKARTA TIMUR Sari, Dini Permata; Silitonga, Julita; Luthfiana, Farisa; Anggraeni, Ria
JIFI (Jurnal Ilmiah Farmasi Imelda) Vol. 9 No. 2 (2026): JIFI (Jurnal Ilmiah Farmasi Imelda)
Publisher : Universitas Imelda Medan

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.52943/jifarmasi.v9i2.2044

Abstract

Tuberculosis (TB) remains a major public health problem in Indonesia, ranking second globally in TB burden. Although Anti-Tuberculosis Drugs (ATDs) are effective in curing TB, prolonged treatment and combination regimens may lead to Adverse Drug Reactions (ADRs), potentially affecting patient adherence and treatment outcomes. This study aimed to identify the types of ADRs experienced by TB patients undergoing ATD therapy at Pasar Rebo General Hospital, East Jakarta, and to analyze the relationship between age, gender, and duration of drug use with ADR occurrence. This research employed a descriptive-analytic retrospective design conducted from June to July 2025. A total of 60 adult TB patients receiving first-line ATD therapy (Isoniazid, Rifampicin, Pyrazinamide, and Ethambutol) were included. Data were collected using questionnaires and analyzed using univariate and multivariate statistical methods with SPSS. Causality assessment of ADRs was performed using the Naranjo algorithm. The results showed that 88.33% of patients experienced ADRs. The most frequently reported symptoms were nausea (48.33%), rash/itching (28.33%), and joint pain (26.67%). Most ADRs were categorized as “Probable” based on the Naranjo score. Multivariate analysis revealed that gender was significantly associated with ADR occurrence (p = 0.041), while age and duration of drug use were not statistically significant. In conclusion, ADRs are common among TB patients receiving ATD therapy, with gastrointestinal and dermatological symptoms being the most prevalent. Gender appears to be an important predictor of ADR risk. Therefore, close clinical monitoring and gender-sensitive pharmacovigilance strategies are essential to ensure patient safety, improve adherence, and optimize TB treatment outcomes.
FORMULASI DAN UJI MUTU FISIK SABUN PADAT MENGANDUNG EKSTRAK LAVENDER (Lavandula angustifolia Mill.) DAN KULIT BATANG KAYU MANIS (Cinnamomum burmanii) Samosir, Sri Rezeki; Syari, Dina Maya; Sari, Mawarni Atika
JIFI (Jurnal Ilmiah Farmasi Imelda) Vol. 9 No. 2 (2026): JIFI (Jurnal Ilmiah Farmasi Imelda)
Publisher : Universitas Imelda Medan

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.52943/jifarmasi.v9i2.2177

Abstract

The manufacture of solid soap combination of lavender leaf & flower extract (Lavandula angustifolia Mill) and cinnamon bark extract (Cinnamomum burmanii) has been carried out. The research method is experimental in the laboratory with a quantitative analysis approach. The sample of this research is from lavender leaf & flower extract (Lavandula angustifolia Mill) and cinnamon bark extract (Cinnamomum burmanii). The research stages include making simplicia, evaporation extraction, phytochemical screening, making solid soap preparations and testing the physical quality of solid soap. The extraction stage uses the maceration method for 3 days with 96% ethanol solvent, the extract obtained using a rotary evaporator. Solid soap from a combination of lavender leaf & flower extract (Lavandula angustifolia Mill) and cinnamon bark extract (Cinnamomum burmanii) is made in 3 formulations, namely 1%, 2%, 3%. Physical quality testing includes organoleptic test, pH test, foam height test, water content test. The results of the organoleptic test showed a brown colored preparation and a solid texture with a distinctive cinnamon aroma. The results of the pH test showed a pH of 11 for all three formulas. The results of the foam height test showed an initial foam height of 6cm – 7cm and a final foam height of the three formulas of 1cm. The results of the water content test at (F1) 1.29%, (F2) 1.03% and at (F3) 1.86%. The results of the study can be concluded that the combination of lavender leaf & flower extract (Lavandula angustifolia Mill) and cinnamon bark extract (Cinnamomum burmanii) can be formulated as a solid soap preparation.
PENGARUH JENIS PELARUT TERHADAP AKTIVITAS ANTIOKSIDAN EKSTRAK KULIT KAYU RARU (Cotylelobium melanoxylon (Hook.f) Pierre) MELALUI UJI DPPH Sibagariang, Nurhadijah; Bangar, Roy Indrianto; Ikhtiari, Refi
JIFI (Jurnal Ilmiah Farmasi Imelda) Vol. 9 No. 2 (2026): JIFI (Jurnal Ilmiah Farmasi Imelda)
Publisher : Universitas Imelda Medan

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.52943/jifarmasi.v9i2.2181

Abstract

UJI AKTIVITAS ANTIOKSIDAN METODE DPPH DARI EKSTRAK ETANOL DAUN SUKUN (Artocarpus altilis L.) MENGGUNAKAN METODE MASERASI Sari, Cindy Kurnia; Razoki, Razoki; Novriani, Erida
JIFI (Jurnal Ilmiah Farmasi Imelda) Vol. 9 No. 2 (2026): JIFI (Jurnal Ilmiah Farmasi Imelda)
Publisher : Universitas Imelda Medan

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.52943/jifarmasi.v9i2.2193

Abstract

Breadfruit leaves (Artocarpus altilis L.) area plant with various health benefits due to their natural chemical compounds, one of which acts as an antioxidant. Antioxidants are compounds that can halt the oxidation process by donating electrons, there by protecting normal cells, fats, and proteins from damage caused by free radicals. The concentration of an antioxidant that causes a 50% reduction in DPPH activity is referred to as the IC50.  The objective of this study was to determine the effectiveness of ethanol extract from breadfruit leaves in combating oxidation using the DPPH method. The results showed an IC50 value of 6.66 ppm for the extract, indicating very strong antioxidant activity, although it was more effective compared to vitamin C, which served as a positive control with an IC50 value of 1.15 ppm. This difference in effectiveness is influenced by the amount of phenolic compounds present and the potential pro-oxidant effects at higher concentrations. In summary, breadfruit leaves have high potential as asource of natural antioxidants and can be used to develop pharmaceutical products to treat degenerative diseases.

Page 13 of 13 | Total Record : 125

 9   10   11   12   13 

Filter by Year

2017 2026


Reset
Filter By Issues
All Issue Vol. 9 No. 2 (2026): JIFI (Jurnal Ilmiah Farmasi Imelda) Vol. 9 No. 1 (2025): JIFI (Jurnal Ilmiah Farmasi Imelda) Vol. 8 No. 2 (2025): JIFI (Jurnal Ilmiah Farmasi Imelda) Vol. 8 No. 1 (2024): JIFI (Jurnal Ilmiah Farmasi Imelda) Vol. 7 No. 2 (2024): JIFI (Jurnal Ilmiah Farmasi Imelda) Vol. 7 No. 1 (2023): JIFI (Jurnal Ilmiah Farmasi Imelda) Vol. 6 No. 2 (2023): JIFI (Jurnal Ilmiah Farmasi Imelda) Vol. 6 No. 1 (2022): JIFI (Jurnal Ilmiah Farmasi Imelda) Vol. 5 No. 2 (2022): JIFI (Jurnal Ilmiah Farmasi Imelda) Vol. 5 No. 1 (2021): JIFI (Jurnal Ilmiah Farmasi Imelda) Vol. 4 No. 2 (2021): JIFI (Jurnal Ilmiah Farmasi Imelda) Vol. 4 No. 1 (2020): JIFI (Jurnal Ilmiah Farmasi Imelda) Vol. 3 No. 2 (2020): JIFI (Jurnal Ilmiah Farmasi Imelda) Vol. 3 No. 1 (2019): JIFI (Jurnal Ilmiah Farmasi Imelda) Vol. 2 No. 2 (2019): JIFI (Jurnal Ilmiah Farmasi Imelda) Vol. 2 No. 1 (2018): JIFI (Jurnal Ilmiah Farmasi Imelda) Vol. 1 No. 2 (2018): JIFI (Jurnal Ilmiah Farmasi Imelda) Vol. 1 No. 1 (2017): JIFI (Jurnal Ilmiah Farmasi Imelda) More Issue